Preview

Medical Journal

Advanced search

COMPREHENSIVE ASSESSMENT OF THE DURATION OF REMISSION IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AFTER CELL THERAPY

https://doi.org/10.51922/1818-426X.2026.3.80

Abstract

Recurrence of polyps in chronic rhinosinusitis with nasal polyps after surgical treatment remains a multifactorial issue, influenced by the endotype of chronic rhinosinusitis with nasal polyps, patient comorbidities, surgical techniques, and regional treatment paradigms. The recurrence rate after surgical treatment remains high, which increases the risk of requiring repeated surgical intervention. This article presents the results of a study evaluating the effectiveness of a biomedical cell product based on olfactory mucosa mesenchymal stem cells in extending the relapse-free period (absence of need for surgery) in patients with chronic rhinosinusitis with nasal polyps. The study included 50 patients divided into three groups: two main groups receiving cell therapy at different times relative to surgical treatment, and a control group receiving only standard treatment. Analysis was performed using Kaplan-Meier methods and Cox regression to assess the time to repeated surgical intervention over a 3-year follow-up period. The results demonstrated a statistically significant extension of the relapse-free period in the combined main group compared to the control (p = 0.023). The probability of a first repeated surgery in the main group was 5.3 times lower than in the control group. The probability of a second repeated surgery in the main group was 1.1 times lower than in the control group. Modeling showed that relapse risk in the control group began to increase within one year post-surgery, whereas it remained stably low in the main group throughout the entire follow-up period.

About the Authors

A. A. Nidzelko
Republican Scientific and Practical Center of Otolaryngology
Belarus

Minsk



E. A. Shulepova
Belarusian State Medical University
Belarus

Minsk



References

1. Ha, J. G. Unraveling the Role of Epithelial Cells in the Development of Chronic Rhinosinusitis /j. G. Ha, H. J. Cho // Int J Mol Sci. – 2023. – Vol. 24, № 18. – P. 14229.

2. Kaboodkhani, R. Achievements and Challenges in Transplantation of Mesenchymal Stem Cells in Otorhinolaryngology / R. Kaboodkhani, D. Mehrabani, F. Karimi-Busheri //j Clin Med. – 2021. – Vol. 10, № 13. – P. 2940.

3. Selvarajah, J. Current and Alternative Therapies for Nasal Mucosa Injury: A Review /j. Selvarajah, A. B. Saim, R. Bt Hj Idrus [et al.] // Int. J. Mol. Sci. – 2020. – Vol. 21. – P. 480.

4. Borzou, B. The Effect of Age and Type of Media on Growth Kinetics of Human Amniotic Fluid Stem Cells / B. Borzou, D. Mehrabani, S. Zare [et al.] // Biopreserv. Biobank. – 2020. – Vol. 18. – P. 389–394.

5. Ryazantsev, S. V. Polipoznyj rinosinusit: osnovnye aspekty protivorecidivnoj terapii i vosstanovleniya nosovogo dyhaniya. [Rhinosinusitis with nasal polyps: main aspects of antirelapse therapy and recovery of nasal breathing] / S. V. Ryazantsev, M. A. Budkovaya, E. S. Artemyeva [et al.] // Meditsinskiy sovet. – 2019. – № 20. – P. 13–18. – doi: 10.21518/2079-701X-2019-20-13-18 [In Russian]

6. Chen, Y. S. Recurrence of Chronic Rhinosinusitis with Nasal Polyps After Surgery: Risk Factors, Predictive Models, and Treatment Approaches with a Focus on Western and Asian Differences / Y. S. Chen, C. Y. Feng, S. H. Su [et al.] // Medicina (Kaunas). – 2025. – Vol. 61, № 9. – P. 1620. – doi: 10.3390/medicina61091620.

7. DeConde, A. S. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis / A. S. DeConde, J. C. Mace, J. M. Levy [et al.] // Laryngoscope. – 2017. – Vol. 127, № 3. – P. 550–555. – doi: 10.1002/lary.26391.

8. Nidel'ko, A. A. Osobennosti rinocitogrammy pri kletochnoj terapii u pacientov s hronicheskim polipoznym rinosinusitom [Features of rhinocytogram in cell therapy in patients with chronic polypous rhinosinusitis] / A. A. Nidel'ko // Evrazijskaya otorinolaringologiya i audiologiya. – 2025. – Vol. 15, № 3. – S. 292–304 [In Russian].

9. Eremenko, Yu. E., Ocenka bezopasnosti primeneniya mezenhimal’nyh stvolovyh kletok obonyatel’noj vystilki dlya terapii hronicheskogo polipoznogo rinosinusita. [Evaluation of the safety of using olfactory mucosal mesenchymal stem cells for the treatment of chronic polypous rhinosinusitis] / Yu. E. Eremenko, E. A. Shulepova, A. A. Nidel'ko, [et al.] // Lechashchij Vrach. – 2025. – № 10 (28). – S. 11–17. – https://doi.org/10.51793/OS.2025.28.10.001 [In Russian].

10. Nidel'ko, A. A. Ocenka kachestva zhizni po SNOT-22 pri kletochnoj terapii u pacientov s hronicheskim polipoznym rinosinusitom [Assessment of quality of life according to SNOT-22 during cell therapy in patients with chronic polypous rhinosinusitis] / A. A. Nidel'ko // Evrazijskaya otorinolaringologiya i audiologiya. – 2025. – Vol. 15, № 4. – C. 495–505 [In Russian].


Review

For citations:


Nidzelko A.A., Shulepova E.A. COMPREHENSIVE ASSESSMENT OF THE DURATION OF REMISSION IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AFTER CELL THERAPY. Medical Journal. 2026;(3):80-88. (In Russ.) https://doi.org/10.51922/1818-426X.2026.3.80

Views: 27

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-426X (Print)